BioSpace News Archive

The decision was unanimously approved by the Boards of Directors of Clariant and Huntsman.

Revenues for the three months ended September 30, 2017 were $25.1 million, an increase of 0.2% compared to revenues of $25.0 million for the three months ended September 30, 2016.

President Trump’s designation of the opioid crisis as a public health emergency takes an important step toward solving a problem that impacts people of all ages and ethnic groups throughout the nation.

China Resources Pharmaceutical filed with the Hong Kong exchange to raise $368.5 million in an investment fund.

MR Solutions is expanding its management team following world-wide sales success of their ground-breaking, cryogen free preclinical MRI scanners.

The Rare Genomics (RG) Institute is delighted to announce the launch of the 2018 BeHEARD (Helping Empower and Accelerate Research Discoveries) science challenge, a global competition that offers rare disease researchers, who traditionally have difficulty attracting funding, grants of cash and the latest life science innovations and technologies.

The company will also host a conference call and an online presentation on October 31, at 2 pm CET.

Relevium Technologies is pleased to announce it has appointed Abis Hussain as the company’s Senior Marketing Officer, overseeing the company’s overall marketing and branding activities for its current and future portfolio of e-brands.

Sprint Bioscience has shown that inhibition of autophagy with the company’s substance SB02024 activates the immune system in the tumor.

The symposium, chaired by Sunil V. Rao, M.D., FSCAI of Duke University Medical Center and featuring faculty from leading cardiovascular institutions, will focus on the benefits of radial access combined with robotic assistance for PCI.